Agepha Pharma Fz patents expiration
1. Lodoco patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10130585 | AGEPHA PHARMA FZ | Methods of treating and/or preventing cardiovascular disease |
Dec, 2034
(10 years from now) | |
| US11026899 | AGEPHA PHARMA FZ | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative |
Jan, 2035
(10 years from now) | |
| US10842762 | AGEPHA PHARMA FZ | Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent |
Jan, 2035
(10 years from now) | |
| US10265281 | AGEPHA PHARMA FZ | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative |
Jan, 2035
(10 years from now) | |
| US10206891 | AGEPHA PHARMA FZ | Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent |
Jan, 2035
(10 years from now) | |
| US9744144 | AGEPHA PHARMA FZ | Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent |
Jan, 2035
(10 years from now) | |
| US11026901 | AGEPHA PHARMA FZ | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative |
Jan, 2035
(10 years from now) | |
| US11026900 | AGEPHA PHARMA FZ | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative |
Jan, 2035
(10 years from now) | |
Drugs and Companies using COLCHICINE ingredient
Market Authorisation Date: 16 June, 2023
Treatment: A method of treating cardiovascular disease; A method for treating and/or reducing the risk of a cardiovascular event; A method of treating and/or reducing the risk of inflammation, atherosclerotic va...
Dosage: TABLET;ORAL
More Information on Dosage
LODOCO family patents
